No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Comparison of two commercial whole body PET systems based on LSO and BGO crystals respectively for brain imaging
1.G. Lucignani, “The neuroimaging approach to the assessment of mild cognitive impairment,” Eur. J. Nucl. Med. Mol. Imaging 33, 745–748 (2006).
2.T. Kawachi, K. Ishii, S. Sakamoto, M. Sasaki, T. Mori, F. Yamashita, H. Matsuda, and E. Mori, “Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease,” Eur. J. Nucl. Med. Mol. Imaging 33, 801–809 (2006).
3.L. Mosconi, S. De Santi, Y. Li, J. Li, J. Zhan, W. H. Tsui, M. Boppana, A. Pupi, and M. J. de Leon, “Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET,” Eur. J. Nucl. Med. Mol. Imaging 33, 210–221 (2006).
4.A. H. Jacobs, A. Thomas, L. W. Kracht, H. Li, C. Dittmar, G. Garlip, N. Galldiks, J. C. Klein, J. Sobesky, R. Hilker, S. Vollmar, K. Herholz, K. Wienhard, and W. D. Heiss, “18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors,” J. Nucl. Med. 46, 1948–1958 (2005).
5.G. Popperl, F. W. Kreth, J. Herms, W. Koch, J. H. Mehrkens, F. J. Gildehaus, H. A. Kretzschmar, J. C. Tonn, and K. Tatsch, “Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?,” J. Nucl. Med. 47, 393–403 (2006).
6.H. Zaidi and M. L. Montandon, “The New Challenges of Brain PET Imaging Technology,” Curr Med Imaging Rev 2, 3–13 (2006).
7.C. Leroy, M. J. Santiago-Ribeiro, C. Comtat, R. Trebossen, V. Brulon, J. L. Martinot, and A. Syrota, “Validation of a high spatial resolution PET camera for the brain imaging of the neuronal dopamine transporter,” J. Nucl. Med. 48, 538–546 (2007).
8.M. Brambilla, C. Secco, M. Dominietto, R. Matheoud, G. Sacchetti, and E. Inglese, “Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard,” J. Nucl. Med. 46, 2083–2091 (2005).
9.D. W. Townsend, J. P. Carney, J. T. Yap, and N. C. Hall, “PET/CT today and tomorrow,” J. Nucl. Med. 45 Suppl. 1, 4S–14S (2004).
10.G. Brix, J. Zaers, L. E. Adam, M. E. Bellemann, H. Ostertag, H. Trojan, U. Haberkorn, J. Doll, F. Oberdorfer, and W. J. Lorenz, “Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association,” J. Nucl. Med. 38, 1614–1623 (1997).
11.NEMA NU2-2001, “National Electrical Manufacturers Association NEMA Standards Publication NU 2-2001: Performance Measurements of Positron Emission Tomographs,” National Electrical Manufacturers Association, Rosslyn, VA (2001).
12.M. E. Daube-Witherspoon and G. Muehllehner, “Treatment of axial data in three-dimensional PET,” J. Nucl. Med. 28, 1717–1724 (1987).
13.C. C. Watson, M. E. Casey, L. Eriksson, T. Mulnix, D. Adams, and B. Bendriem, “NEMA NU 2 performance tests for scanners with intrinsic radioactivity,” J. Nucl. Med. 45, 822–826 (2004).
14.S. Yamamoto, H. Horii, M. Hurutani, K. Matsumoto, and M. Senda, “Investigation of single, random, and true counts from natural radioactivity in LSO-based clinical PET,” Ann. Nucl. Med. 19, 109–114 (2005).
15.M. Defrise, P. E. Kinahan, D. W. Townsend, C. Michel, M. Sibomana, and D. F. Newport, “Exact and approximate rebinning algorithms for 3-D PET data,” IEEE Trans. Nucl. Sci. 16, 145 (1997).
16.P. E. Kinahan and J. G. Rogers, “Analytic 3D image reconstruction using all detected events,” IEEE Trans. Nucl. Sci. 36, 964–968 (1989).
18.C. Comtat, P. E. Kinahan, M. Drefrise, C. Michel, and D. W. Townsend, “Fast reconstruction of 3D PET data with accurate statistical modelling,” IEEE Trans. Nucl. Sci. 45, 1083–1089 (1998).
20.L. N. Loo, K. Doi, and C. E. Metz, “A comparison of physical image quality indices and observer performance in the radiographic detection of nylon beads,” Phys. Med. Biol. 29, 837–856 (1984).
21.K. Herholz, D. Perani, E. Salmon, G. Franck, F. Fazio, W. D. Heiss, and D. Comar, “Comparability of FDG PET studies in probable Alzheimer’s disease,” J. Nucl. Med. 34, 1460–1466 (1993).
22.A. Ciarmiello, M. Cannella, S. Lastoria, M. Simonelli, L. Frati, D. C. Rubinsztein, and F. Squitieri, “Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease,” J. Nucl. Med. 47, 215–222 (2006).
23.G. Brix, U. Lechel, G. Glatting, S. I. Ziegler, W. Munzing, S. P. Muller, and T. Beyer, “Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations,” J. Nucl. Med. 46, 608–613 (2005).
24.R. Boellaard, A. van Lingen, and A. A. Lammertsma, “Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling,” J. Nucl. Med. 42, 808–825 (2001).
25.M. Lubberink, R. Boellaard, A. P. van der Weerdt, F. C. Visser, and A. A. Lammertsma, “Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET,” J. Nucl. Med. 45, 2008–2015 (2004).
Article metrics loading...
Full text loading...
Most read this month